KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Exam preparation, Self-tuition – preparation for exam
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Seminar, Presentation, Group 1-2, Anders Undén, Literature seminars
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Seminar, Presentation, Group 5-6, Anders Undén, Literature seminars
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Self-study, Literature seminar preparation
Abstract to Mondo
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Exam preparation, Self-tuition – preparation for exam
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Maxime Gestin, Lab 4: Receptor binding part 1
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Maxime Gestin, Lab 4: Receptor binding part 1
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Maxime Gestin, Lab 4: Receptor binding part 1
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Lecture, Anders Undén, Lecture 17. Monoamines I
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Lecture, Anders Undén, Lecture 18. Monoamines II
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Lecture, Anders Undén, Lecture 19. Neuropharmacology and pathology
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Test, Dugga 2
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Lecture, Anders Undén, Lecture 20.
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Lecture, Henrietta Nielsen, Lecture 22. Neurotransmission in the retina
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Lecture, Anders Undén, Lecture 21. Neurochemical aspects of pain
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Exam preparation, Anders Undén, Review of previous exams, Q&A
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Course conclusion , Anders Undén, Self-assessment, reflection group discussion. Exam discussion – course evaluation
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Examination, Written exam, KN7001
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Self-study
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Self-study, Literature seminar preparation
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Maxime Gestin, Lab 4: Receptor binding part 1
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Maxime Gestin, Lab 4: Receptor binding part 1
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Maxime Gestin, Lab 4: Receptor binding part 1
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Exam preparation, Self-tuition – preparation for exam
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Seminar, Presentation, Group 3-4, Anders Undén, Literature seminars
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Presentation, Presentation and summary of lab 1-5
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 1
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 2
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Maxime Gestin, Lab 4: Receptor binding part 2
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Group 6, Daniel Patrick Twohig, Lab 3: IP3 inhibition
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 4, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 1
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 4, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 2
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Maxime Gestin, Lab 4: Receptor binding part 2
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 4-5, Daniel Patrick Twohig, Lab 3: IP3 inhibition
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1-2, Daniel Patrick Twohig, Lab 3: IP3 inhibition
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Maxime Gestin, Lab 4: Receptor binding part 2